サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1790425

アレルギー・自己免疫疾患診断薬の市場規模、シェア、動向分析レポート：製品・サービス別、検査タイプ別、診断タイプ別、最終用途別、地域別、セグメント別予測、2025年～2033年

Allergy And Autoimmune Disease Diagnostics Market Size, Share & Trends Analysis Report By Product & Service (Allergy Diagnostics), By Test Type, By Diagnostics Type, By End Use, By Region, And Segment Forecasts, 2025 - 2033

出版日
ページ情報
英文 136 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.50円
アレルギー・自己免疫疾患診断薬の市場規模、シェア、動向分析レポート：製品・サービス別、検査タイプ別、診断タイプ別、最終用途別、地域別、セグメント別予測、2025年～2033年
出版日: 2025年07月21日
発行: Grand View Research
ページ情報: 英文 136 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アレルギー・自己免疫疾患診断薬市場のサマリー

アレルギー・自己免疫疾患診断薬の世界市場規模は、2024年に113億8,000万米ドルと推計され、2033年には250億2,000万米ドルに達すると予測され、2025年から2033年までのCAGRは5.41%で成長すると予測されます。この市場は、アレルギー反応や自己免疫疾患など幅広い免疫関連疾患の検出とモニタリングに対応しています。

成長を支えているのは、慢性免疫疾患の罹患率の上昇、一般市民や臨床医の意識の高まり、イムノアッセイや分子プラットフォームなどの診断手法の技術的向上です。診断精度、スピード、アクセシビリティを向上させるための継続的な取り組み、特にポイントオブケア形式やマルチプレックス検査は、この状況を大きく変えつつあります。検査室インフラの拡大、デジタルツールの統合、個別化免疫診断への関心は、疾患の早期発見と長期管理戦略に貢献しています。バイオマーカー研究とAI主導型分析における革新は、複雑な自己免疫プロファイルにおける診断精度をさらにサポートすると期待されています。

米国疾病予防管理センター（CDC）が2023年1月付のプレスリリースで発表した2021年国民健康調査（NHIS）によると、米国では成人のほぼ3人に1人、小児の4人に1人以上が季節性アレルギー、湿疹、食物アレルギーがあると報告しています。成人および小児の約6％が食物アレルギーに罹患しており、その割合は他の人種・民族グループと比較して非ヒスパニック系黒人の間で顕著に高いです。これらの数値は、多様な集団におけるアレルギー関連疾患の診断需要の高まりを反映しており、アレルギー・自己免疫疾患診断薬業界におけるより正確で包括的な検査アプローチの必要性を強調しています。

さらに、この市場では、在宅検査や分散型検査ソリューションの統合が進んでおり、従来の臨床環境を超えて診断への幅広いアクセスが可能となっています。診断薬開発企業、公衆衛生機関、民間プロバイダー間の協力により、地域の保健所や薬局での検査利用が強化されつつあります。これらの開発に加えて、免疫学研究への投資の増加や、国の医療プログラムによる診断の適用範囲の拡大により、アレルギー・自己免疫疾患診断薬市場は今後数年間でその地位を強化すると予想されます。

目次

第1章 アレルギー・自己免疫疾患診断薬市場：調査手法と範囲

第2章 アレルギー・自己免疫疾患診断薬市場：エグゼクティブサマリー

  • 市場スナップショット
  • 製品・サービス別と検査タイプ別のスナップショット
  • 診断タイプ別のスナップショット
  • 最終用途別のスナップショット
  • 競合情勢のスナップショット

第3章 アレルギー・自己免疫疾患診断薬市場の変数、動向、および範囲

  • 市場セグメンテーションと範囲
  • 市場系統の見通し
    • 親市場の見通し
    • 関連/補助市場展望
  • 市場力学
  • 市場促進要因分析
    • 免疫関連疾患の有病率の上昇
    • 早期かつ個別化された診断への移行
    • 分散型および在宅ベースの検査の拡大
  • 市場抑制要因分析
    • 高度な診断技術の高コスト
    • 新興市場における診断不足と認知度の低さ：
    • 規制と償還の障壁
  • ポーターのファイブフォース分析
  • PESTLE分析
  • パイプライン分析

第4章 アレルギー・自己免疫疾患診断薬市場：製品・サービス別の推定・動向分析

  • アレルギー・自己免疫疾患診断薬市場：製品・サービス別の変動分析
  • アレルギー診断
    • 機器
    • 消耗品
    • サービス
  • 自己免疫疾患の診断
    • 機器
    • 消耗品
    • サービス

第5章 アレルギー・自己免疫疾患診断薬市場：検査タイプ別の推定・動向分析

  • アレルギー・自己免疫疾患診断薬市場：検査タイプ別の変動分析
  • アレルギー診断
    • 生体内試験
    • 試験管内試験
    • 自己免疫疾患の診断

第6章 アレルギー・自己免疫疾患診断薬市場：診断タイプ別の推定・動向分析

  • アレルギー・自己免疫疾患診断薬市場：診断タイプ別の変動分析
  • アレルギー診断
    • 食品
    • 吸入
    • 薬
    • その他のアレルゲン
  • 自己免疫疾患の診断
    • 全身性自己免疫疾患の診断
    • 局所的自己免疫疾患の診断

第7章 アレルギー・自己免疫疾患診断薬市場：最終用途別の推定・動向分析

  • アレルギー・自己免疫疾患診断薬市場：最終用途別の変動分析
  • アレルギー診断
    • 病院と診療所
    • 診断研究所
    • 調査機関
    • その他
  • 自己免疫診断
    • 病院と診療所
    • 診断研究所
    • 研究機関
    • その他

第8章 アレルギー・自己免疫疾患診断薬市場：地域別のビジネス分析

  • 地域別の市場のスナップショット
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第9章 競合情勢

  • 企業分類
  • 戦略マッピング
    • 新製品・新サービスの発売
    • パートナーシップ
    • 取得
    • コラボレーション
    • 資金調達
  • 主要企業の市場シェア分析（2024年）
  • 企業ヒートマップ分析
  • 企業プロファイル
    • THERMO FISHER SCIENTIFIC, INC.
    • HYCOR BIOMEDICAL
    • EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG（PERKINELMER, INC.）
    • OMEGA DIAGNOSTICS GROUP PLC
    • LINCOLN DIAGNOSTICS, INC.
    • AESKU.GROUP GMBH
    • MINARIS MEDICAL AMERICA, INC.
    • HOB BIOTECH GROUP CORP., LTD.
    • DASIT GROUP SPA
    • R-BIOPHARM AG
    • BIOMERIEUX
    • SIEMENS HEALTHCARE GMBH
    • HOFFMANN-LA ROCHE LTD
    • ABBOTT
    • BECKMAN COULTER, INC.
    • DANAHER CORPORATION
    • QUEST DIAGNOSTICS
    • NOVA DIAGNOSTICS PTE LTD.
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Allergy and Autoimmune Disease Diagnostics Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global Allergy and Autoimmune Disease Diagnostics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 5 Global Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 6 Global Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 7 Global Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 8 North America Allergy and Autoimmune Disease Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 9 North America Allergy and Autoimmune Disease Diagnostics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 10 North America Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 11 North America Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 12 North America Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13 U.S. Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 14 U.S. Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 15 U.S. Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 16 U.S. Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17 Canada Allergy and Autoimmune Disease Diagnostics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 18 Canada Allergy and Autoimmune Disease Diagnostics Market, by Product and Service, 2021 - 2033 (USD Million)
  • Table 19 Canada Allergy and Autoimmune Disease Diagnostics Market, by Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 20 Canada Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 21 Mexico Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 22 Mexico Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 23 Mexico Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 24 Mexico Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 25 Europe Allergy and Autoimmune Disease Diagnostics Market, by country, 2021 - 2033 (USD Million)
  • Table 26 Europe Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 27 Europe Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 28 Europe Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 29 Europe Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30 UK Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 31 UK Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 32 UK Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 33 UK Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 34 Germany Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 35 Germany Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 36 Germany Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 37 Germany Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 38 France Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 39 France Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 40 France Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 41 France Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42 Italy Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 43 Italy Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 44 Italy Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 45 Italy Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 46 Spain Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 47 Spain Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 48 Spain Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 49 Spain Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 50 Sweden Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 51 Sweden Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 52 Sweden Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 53 Sweden Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 54 Norway Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 55 Norway Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 56 Norway Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 57 Norway Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58 Denmark Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 59 Denmark Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 60 Denmark Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 61 Denmark Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Allergy and Autoimmune Disease Diagnostics Market, by country, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 67 Japan Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 68 Japan Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 69 Japan Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 70 Japan Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 71 China Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 72 China Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 73 China Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 74 China Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 75 India Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 76 India Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 77 India Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 78 India Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 79 Australia Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 80 Australia Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 81 Australia Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 82 Australia Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 83 Thailand Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 84 Thailand Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 85 Thailand Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 86 Thailand Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 87 South Korea Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 88 South Korea Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 89 South Korea Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 90 South Korea Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 91 Latin America Allergy and Autoimmune Disease Diagnostics Market, by country, 2021 - 2033 (USD Million)
  • Table 92 Latin America Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 93 Latin America Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 94 Latin America Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 95 Latin America Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 96 Brazil Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 97 Brazil Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 98 Brazil Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 99 Brazil Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 100 Argentina Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 101 Argentina Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 102 Argentina Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 103 Argentina Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 104 MEA Allergy and Autoimmune Disease Diagnostics Market, by country, 2021 - 2033 (USD Million)
  • Table 105 MEA Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 106 MEA Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 107 MEA Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 108 MEA Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 109 South Africa Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 110 South Africa Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 111 South Africa Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 112 South Africa Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 116 Saudi Arabia Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 117 UAE Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 118 UAE Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 119 UAE Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 120 UAE Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD)
  • Table 122 Kuwait Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 124 Kuwait Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global Allergy and Autoimmune Disease Diagnostics Market- Key market driver analysis
  • Fig. 7 Global Allergy and Autoimmune Disease Diagnostics Market - Key market restraint analysis
  • Fig. 8 Penetration & growth prospect mapping
  • Fig. 9 Global Allergy and Autoimmune Disease Diagnostics Market - Porter's analysis
  • Fig. 10 Global Allergy and Autoimmune Disease Diagnostics Market - PESTEL analysis
  • Fig. 11 Global Allergy and Autoimmune Disease Diagnostics Market Product and Service outlook key takeaways
  • Fig. 12 Global Allergy and Autoimmune Disease Diagnostics Market: Product and Service movement analysis
  • Fig. 13 Allergy Diagnostics market estimates, 2021 - 2033 (USD Million)
  • Fig. 14 Instruments market estimates, 2021 - 2033 (USD Million)
  • Fig. 15 Consumables market estimates, 2021 - 2033 (USD Million)
  • Fig. 16 Services market estimates, 2021 - 2033 (USD Million)
  • Fig. 17 Autoimmune Disease Diagnostics market estimates, 2021 - 2033 (USD Million)
  • Fig. 18 Instruments market estimates, 2021 - 2033 (USD Million)
  • Fig. 19 Consumables market estimates, 2021 - 2033 (USD Million)
  • Fig. 20 Services market estimates, 2021 - 2033 (USD Million)
  • Fig. 21 Global Allergy and Autoimmune Disease Diagnostics Market Test Type outlook key takeaways
  • Fig. 22 Global Allergy and Autoimmune Disease Diagnostics Market: Test Type movement analysis
  • Fig. 23 Allergy Diagnostics market estimates, 2021 - 2033 (USD Million)
  • Fig. 24 In vivo Test market estimates, 2021 - 2033 (USD Million)
  • Fig. 25 Skin Prick Test market estimates, 2021 - 2033 (USD Million)
  • Fig. 26 Intradermal Test market estimates, 2021 - 2033 (USD Million)
  • Fig. 27 Patch Test market estimates, 2021 - 2033 (USD Million)
  • Fig. 28 In vitro Test market estimates, 2021 - 2033 (USD Million)
  • Fig. 29 Autoimmune Disease Diagnostics Test market estimates, 2021 - 2033 (USD Million)
  • Fig. 30 Antinuclear Antibody Tests market estimates, 2021 - 2033 (USD Million)
  • Fig. 31 Autoantibody Tests estimates, 2021 - 2033 (USD Million)
  • Fig. 32 C-reactive Protein (CRP) market estimates, 2021 - 2033 (USD Million)
  • Fig. 33 Complete Blood Count (CBC) market estimates, 2021 - 2033 (USD Million)
  • Fig. 34 Urinalysis market estimates, 2021 - 2033 (USD Million)
  • Fig. 35 Others market estimates, 2021 - 2033 (USD Million)
  • Fig. 36 Global Allergy and Autoimmune Disease Diagnostics Market Diagnostics Type outlook key takeaways
  • Fig. 37 Global Allergy and Autoimmune Disease Diagnostics Market: Diagnostics Type movement analysis
  • Fig. 38 Allergy diagnostics market estimates, 2021 - 2033 (USD Million)
  • Fig. 39 Food market estimates, 2021 - 2033 (USD Million)
  • Fig. 40 Dairy products market estimates, 2021 - 2033 (USD Million)
  • Fig. 41 Poultry Products market estimates, 2021 - 2033 (USD Million)
  • Fig. 42 Tree nuts market estimates, 2021 - 2033 (USD Million)
  • Fig. 43 Peanuts market estimates, 2021 - 2033 (USD Million)
  • Fig. 44 Shellfish market estimates, 2021 - 2033 (USD Million)
  • Fig. 45 Wheat market estimates, 2021 - 2033 (USD Million)
  • Fig. 46 Soys market estimates, 2021 - 2033 (USD Million)
  • Fig. 47 Other food allergens market estimates, 2021 - 2033 (USD Million)
  • Fig. 48 Inhaled market estimates, 2021 - 2033 (USD Million)
  • Fig. 49 Drug market estimates, 2021 - 2033 (USD Million)
  • Fig. 50 Other allergens market estimates, 2021 - 2033 (USD Million)
  • Fig. 51 Autoimmune disease diagnostics market estimates, 2021 - 2033 (USD Million)
  • Fig. 52 Systemic autoimmune disease diagnostics market estimates, 2021 - 2033 (USD Million)
  • Fig. 53 Rheumatoid Arthritis market estimates, 2021 - 2033 (USD Million)
  • Fig. 54 Ankylosing Spondylitis market estimates, 2021 - 2033 (USD Million)
  • Fig. 55 Systemic Lupus Erythematosus (SLE) market estimates, 2021 - 2033 (USD Million)
  • Fig. 56 Others market estimates, 2021 - 2033 (USD Million)
  • Fig. 57 Localized Autoimmune Disease Diagnostics market estimates, 2021 - 2033 (USD Million)
  • Fig. 58 Multiple Sclerosis market estimates, 2021 - 2033 (USD Million)
  • Fig. 59 Type 1 Diabetes market estimates, 2021 - 2033 (USD Million)
  • Fig. 60 Hashimoto's Thyroiditis market estimates, 2021 - 2033 (USD Million)
  • Fig. 61 Idiopathic Thrombocytopenic Purpura market estimates, 2021 - 2033 (USD Million)
  • Fig. 62 Others market estimates, 2021 - 2033 (USD Million)
  • Fig. 63 Global Allergy and Autoimmune Disease Diagnostics Market end use outlook key takeaways
  • Fig. 64 Global Allergy and Autoimmune Disease Diagnostics Market: end use movement analysis
  • Fig. 65 Allergy Diagnostics market estimates, 2021 - 2033 (USD Million)
  • Fig. 66 Hospitals & Clinics market estimates, 2021 - 2033 (USD Million)
  • Fig. 67 Diagnostics Laboratories market estimates, 2021 - 2033 (USD Million)
  • Fig. 68 Research Institutions market estimates, 2021 - 2033 (USD Million)
  • Fig. 69 Others market estimates, 2021 - 2033 (USD Million)
  • Fig. 70 Autoimmune Diagnostics market estimates, 2021 - 2033 (USD Million)
  • Fig. 71 Hospitals & Clinics market estimates, 2021 - 2033 (USD Million)
  • Fig. 72 Diagnostics Laboratories market estimates, 2021 - 2033 (USD Million)
  • Fig. 73 Research Institutions market estimates, 2021 - 2033 (USD Million)
  • Fig. 74 Others market estimates, 2021 - 2033 (USD Million)
  • Fig. 75 Regional marketplace: Key takeaways
  • Fig. 76 Global Allergy and Autoimmune Disease Diagnostics Market: Regional movement analysis
  • Fig. 77 North America Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 78 U.S. Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 79 Canada Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 80 Mexico Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 81 Europe Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 82 UK Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 83 Germany Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 84 France Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 85 Spain Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 86 Italy Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 87 Denmark Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 88 Sweden Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 89 Norway Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 90 Asia Pacific Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 91 Japan Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 92 China Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 93 India Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 94 South Korea Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 95 Australia Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 96 Thailand Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 97 Latin America Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 98 Brazil Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 99 Argentina Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 100 MEA Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 101 South Africa Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 102 Saudi Arabia Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 103 UAE Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 104 Kuwait Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 105 Strategy framework
目次
Product Code: GVR-4-68040-681-7

Allergy And Autoimmune Disease Diagnostics Market Summary

The global allergy and autoimmune disease diagnostics market size was estimated at USD 11.38 billion in 2024 and is projected to reach USD 25.02 billion by 2033, growing at a CAGR of 5.41% from 2025 to 2033. This market addresses the detection and monitoring of immune-related conditions, spanning a wide range of allergic reactions and autoimmune disorders.

Growth is being supported by the rising incidence of chronic immune conditions, greater public and clinical awareness, and technological improvements in diagnostic modalities such as immunoassays and molecular platforms. Ongoing efforts to improve diagnostic accuracy, speed, and accessibility, especially through point-of-care formats and multiplex testing, are reshaping the landscape. Expanding laboratory infrastructure, integration of digital tools, and interest in personalized immunodiagnostics are contributing to early disease detection and long-term management strategies. Innovations in biomarker research and AI-driven analysis are expected to further support diagnostic precision in complex autoimmune profiles.

According to the National Health Interview Survey (NHIS), 2021, published by the U.S. Centers for Disease Control and Prevention (CDC) in a press release dated January 2023, nearly 1 in 3 adults and more than 1 in 4 children in the U.S. reported having a seasonal allergy, eczema, or food allergy. Around 6% of both adults and children suffer from a food allergy, with the rate being notably higher among Black, non-Hispanic individuals compared to other racial and ethnic groups. These figures reflect the growing diagnostic demand for allergy-related conditions across diverse populations, emphasizing the need for more accurate and inclusive testing approaches in the allergy and autoimmune disease diagnostics industry.

In addition, the market is witnessing greater integration of home-based and decentralized testing solutions, enabling broader access to diagnostics beyond traditional clinical settings. Collaborations between diagnostic developers, public health agencies, and private providers are enhancing the availability of tests in community health centers and pharmacies. These developments, combined with rising investments in immunology research and the expansion of diagnostic coverage under national health programs, are expected to strengthen the position of the allergy and autoimmune disease diagnostics market over the coming years.

Global Allergy And Autoimmune Disease Diagnostics Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global allergy and autoimmune disease diagnostics market report based on product and service, diagnostics type, test type, end use, and region:

  • Product and Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Allergy Diagnostics
    • Instruments
    • Consumables
    • Services
  • Autoimmune Disease Diagnostics
    • Instruments
    • Consumables
    • Services
  • Test Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Allergy Diagnostics
    • In vivo Test
    • Skin Prick Test
    • Intradermal Test
    • Patch Test
    • In vitro Test
    • Autoimmune Disease Diagnostics
    • Antinuclear Antibody Tests
    • Autoantibody Tests
    • C-reactive Protein (CRP)
    • Complete Blood Count (CBC)
    • Urinalysis
    • Others
  • Diagnostics Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Allergy Diagnostics
    • Food
    • Dairy Products
    • Poultry Products
    • Tree Nuts
    • Peanuts
    • Shellfish
    • Wheat
    • Soys
    • Other Food Allergens
    • Inhaled
    • Drug
    • Other Allergens
  • Autoimmune Disease Diagnostics
    • Systemic Autoimmune Disease Diagnostics
    • Rheumatoid Arthritis
    • Ankylosing Spondylitis
    • Systemic Lupus Erythematosus (SLE)
    • Others
    • Localized Autoimmune Disease Diagnostics
    • Multiple Sclerosis
    • Type 1 Diabetes
    • Hashimoto's Thyroiditis
    • Idiopathic Thrombocytopenic Purpura
    • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Allergy Diagnostics
    • Hospitals & Clinics
    • Diagnostics Laboratories
    • Research Institutions
    • Others
  • Autoimmune Diagnostics
    • Hospitals & Clinics
    • Diagnostics Laboratories
    • Research Institutions
    • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Allergy and Autoimmune Disease Diagnostics Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product and Service Segment
      • 1.1.1.2. Test Type Segment
      • 1.1.1.3. Diagnostics Type Segment
      • 1.1.1.4. End Use segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Allergy and Autoimmune Disease Diagnostics Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Product and Service and Test type Snapshot
  • 2.3. Diagnostics Type Snapshot
  • 2.4. End Use Snapshot
  • 2.5. Competitive Landscape Snapshot

Chapter 3. Allergy and Autoimmune Disease Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Rising Prevalence of Immune-Related Disorders
    • 3.4.2. Shift Toward Early and Personalized Diagnosis
    • 3.4.3. Expansion of Decentralized and Home-Based Testing
  • 3.5. Market Restraint Analysis
    • 3.5.1. High Cost of Advanced Diagnostic Technologies
    • 3.5.2. Underdiagnosis and Limited Awareness in Emerging Markets:
    • 3.5.3. Regulatory and Reimbursement Barriers
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. Allergy and Autoimmune Disease Diagnostics Market: Product and Service Estimates & Trend Analysis

  • 4.1. Allergy and Autoimmune Disease Diagnostics Market: Product and Service Movement Analysis
  • 4.2. Allergy Diagnostics
    • 4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.2.2. Instruments
      • 4.2.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.2.3. Consumables
      • 4.2.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.2.4. Services
      • 4.2.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3. Autoimmune Disease Diagnostics
    • 4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. Instruments
      • 4.3.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3. Consumables
      • 4.3.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.4. Services
      • 4.3.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Allergy and Autoimmune Disease Diagnostics Market: Test Type Estimates & Trend Analysis

  • 5.1. Allergy and Autoimmune Disease Diagnostics Market: Test Type Movement Analysis
  • 5.2. Allergy Diagnostics
    • 5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.2.2. In vivo Test
      • 5.2.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.2.2.2. Skin Prick Test
        • 5.2.2.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.2.2.3. Intradermal Test
        • 5.2.2.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.2.2.4. Patch Test
        • 5.2.2.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.2.3. In vitro Test
      • 5.2.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.2.4. Autoimmune Disease Diagnostics
      • 5.2.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.2.4.2. 'Antinuclear Antibody Tests
        • 5.2.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.2.4.3. Autoantibody Tests
        • 5.2.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.2.4.4. C-reactive Protein (CRP)
        • 5.2.4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.2.4.5. Complete Blood Count (CBC)
        • 5.2.4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.2.4.6. Urinalysis
        • 5.2.4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.2.4.7. Others
        • 5.2.4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Allergy and Autoimmune Disease Diagnostics Market: Diagnostics Type Estimates & Trend Analysis

  • 6.1. Allergy and Autoimmune Disease Diagnostics Market: Technology Movement Analysis
  • 6.2. Allergy Diagnostics
    • 6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.2. Food
      • 6.2.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.2.2.2. Dairy Products
        • 6.2.2.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.2.2.3. Poultry Products
        • 6.2.2.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.2.2.4. Tree Nuts
        • 6.2.2.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.2.2.5. Peanuts
        • 6.2.2.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.2.2.6. Shellfish
        • 6.2.2.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.2.2.7. Wheat
        • 6.2.2.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.2.2.8. Soys
        • 6.2.2.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.2.2.9. Other Food Allergens
        • 6.2.2.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.3. Inhaled
      • 6.2.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.4. Drug
      • 6.2.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.5. Other Allergens
      • 6.2.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3. Autoimmune Disease Diagnostics
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. Systemic Autoimmune Disease Diagnostics
      • 6.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.2.2. Rheumatoid Arthritis
        • 6.3.2.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.2.3. Ankylosing Spondylitis
        • 6.3.2.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.2.4. Systemic Lupus Erythematosus (SLE)
        • 6.3.2.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.2.5. Others
        • 6.3.2.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Localized Autoimmune Disease Diagnostics
      • 6.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.3.2. Multiple Sclerosis
        • 6.3.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.3.3. Type 1 Diabetes
        • 6.3.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.3.4. Hashimoto's Thyroiditis
        • 6.3.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.3.5. Idiopathic Thrombocytopenic Purpura
        • 6.3.3.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.3.6. Others
        • 6.3.3.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Allergy and Autoimmune Disease Diagnostics Market: End Use Estimates & Trend Analysis

  • 7.1. Allergy and Autoimmune Disease Diagnostics Market: End Use Movement Analysis
  • 7.2. Allergy Diagnostics
    • 7.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.2. Hospitals & Clinics
      • 7.2.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.3. Diagnostics Laboratories
      • 7.2.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.4. Research Institutions
      • 7.2.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.5. Others
      • 7.2.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3. Autoimmune Diagnostics
    • 7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. Hospitals & Clinics
      • 7.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Diagnostics Laboratories
      • 7.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Research Institutions
      • 7.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.5. Others
      • 7.3.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Allergy and Autoimmune Disease Diagnostics Market: Regional Business Analysis

  • 8.1. Regional Market Snapshot
  • 8.2. North America
    • 8.2.1. North America Allergy and Autoimmune Disease Diagnostics Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.2.2.2. Key Country Dynamics
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Reimbursement Scenario
      • 8.2.2.5. Competitive Scenario
    • 8.2.3. Canada
      • 8.2.3.1. Canada Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.2.3.2. Key Country Dynamics
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Reimbursement Scenario
      • 8.2.3.5. Competitive Scenario
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.2.4.2. Key Country Dynamics
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Reimbursement Scenario
      • 8.2.4.5. Competitive Scenario
  • 8.3. Europe
    • 8.3.1. Europe Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.2.2. Key Country Dynamics
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Reimbursement Scenario
      • 8.3.2.5. Competitive Scenario
    • 8.3.3. Germany
      • 8.3.3.1. Germany Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.3.2. Key Country Dynamics
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Reimbursement Scenario
      • 8.3.3.5. Competitive Scenario
    • 8.3.4. Spain
      • 8.3.4.1. Spain Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.4.2. Key Country Dynamics
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Reimbursement Scenario
      • 8.3.4.5. Competitive Scenario
    • 8.3.5. France
      • 8.3.5.1. France Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.5.2. Key Country Dynamics
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Reimbursement Scenario
      • 8.3.5.5. Competitive Scenario
    • 8.3.6. Italy
      • 8.3.6.1. Italy Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.6.2. Key Country Dynamics
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Reimbursement Scenario
      • 8.3.6.5. Competitive Scenario
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.7.2. Key Country Dynamics
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Reimbursement Scenario
      • 8.3.7.5. Competitive Scenario
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.8.2. Key Country Dynamics
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Reimbursement Scenario
      • 8.3.8.5. Competitive Scenario
    • 8.3.9. Norway
      • 8.3.9.1. Norway Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.9.2. Key Country Dynamics
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Reimbursement Scenario
      • 8.3.9.5. Competitive Scenario
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.2.2. Key Country Dynamics
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Reimbursement Scenario
      • 8.4.2.5. Competitive Scenario
    • 8.4.3. China
      • 8.4.3.1. China Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.3.2. Key Country Dynamics
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Reimbursement Scenario
      • 8.4.3.5. Competitive Scenario
    • 8.4.4. India
      • 8.4.4.1. India Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.4.2. Key Country Dynamics
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Reimbursement Scenario
      • 8.4.4.5. Competitive Scenario
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.5.2. Key Country Dynamics
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Reimbursement Scenario
      • 8.4.5.5. Competitive Scenario
    • 8.4.6. Thailand
      • 8.4.6.1. Thailand Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.6.2. Key Country Dynamics
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Reimbursement Scenario
      • 8.4.6.5. Competitive Scenario
    • 8.4.7. Australia
      • 8.4.7.1. Australia Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.7.2. Key Country Dynamics
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Reimbursement Scenario
      • 8.4.7.5. Competitive Scenario
  • 8.5. Latin America
    • 8.5.1. Latin America Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.5.2.2. Key Country Dynamics
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement Scenario
      • 8.5.2.5. Competitive Scenario
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.5.3.2. Key Country Dynamics
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement Scenario
      • 8.5.3.5. Competitive Scenario
  • 8.6. MEA
    • 8.6.1. MEA Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.6.2.2. Key Country Dynamics
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement Scenario
      • 8.6.2.5. Competitive Scenario
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.6.3.2. Key Country Dynamics
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Reimbursement Scenario
      • 8.6.3.5. Competitive Scenario
    • 8.6.4. UAE
      • 8.6.4.1. UAE Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.6.4.2. Key Country Dynamics
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Reimbursement Scenario
      • 8.6.4.5. Competitive Scenario
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.6.5.2. Key Country Dynamics
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Reimbursement Scenario
      • 8.6.5.5. Competitive Scenario

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
    • 9.2.1. New Product and Service Launch
    • 9.2.2. Partnerships
    • 9.2.3. Acquisition
    • 9.2.4. Collaboration
    • 9.2.5. Funding
  • 9.3. Key Company Market Share Analysis, 2024
  • 9.4. Company Heat Map Analysis
  • 9.5. Company Profiles
    • 9.5.1. THERMO FISHER SCIENTIFIC, INC.
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product and Service Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. HYCOR BIOMEDICAL
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product and Service Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG (PERKINELMER, INC.)
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product and Service Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. OMEGA DIAGNOSTICS GROUP PLC
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product and Service Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. LINCOLN DIAGNOSTICS, INC.
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product and Service Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. AESKU.GROUP GMBH
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product and Service Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. MINARIS MEDICAL AMERICA, INC.
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product and Service Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. HOB BIOTECH GROUP CORP., LTD.
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product and Service Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. DASIT GROUP SPA
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product and Service Benchmarking
      • 9.5.9.4. Strategic Initiatives
    • 9.5.10. R-BIOPHARM AG
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product and Service Benchmarking
      • 9.5.10.4. Strategic Initiatives
    • 9.5.11. BIOMERIEUX
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Financial Performance
      • 9.5.11.3. Product and Service Benchmarking
      • 9.5.11.4. Strategic Initiatives
    • 9.5.12. SIEMENS HEALTHCARE GMBH
      • 9.5.12.1. Company Overview
      • 9.5.12.2. Financial Performance
      • 9.5.12.3. Product and Service Benchmarking
      • 9.5.12.4. Strategic Initiatives
    • 9.5.13. HOFFMANN-LA ROCHE LTD
      • 9.5.13.1. Company Overview
      • 9.5.13.2. Financial Performance
      • 9.5.13.3. Product and Service Benchmarking
      • 9.5.13.4. Strategic Initiatives
    • 9.5.14. ABBOTT
      • 9.5.14.1. Company Overview
      • 9.5.14.2. Financial Performance
      • 9.5.14.3. Product and Service Benchmarking
      • 9.5.14.4. Strategic Initiatives
    • 9.5.15. BECKMAN COULTER, INC.
      • 9.5.15.1. Company Overview
      • 9.5.15.2. Financial Performance
      • 9.5.15.3. Product and Service Benchmarking
      • 9.5.15.4. Strategic Initiatives
    • 9.5.16. DANAHER CORPORATION
      • 9.5.16.1. Company Overview
      • 9.5.16.2. Financial Performance
      • 9.5.16.3. Product and Service Benchmarking
      • 9.5.16.4. Strategic Initiatives
    • 9.5.17. QUEST DIAGNOSTICS
      • 9.5.17.1. Company Overview
      • 9.5.17.2. Financial Performance
      • 9.5.17.3. Product and Service Benchmarking
      • 9.5.17.4. Strategic Initiatives
    • 9.5.18. NOVA DIAGNOSTICS PTE LTD.
      • 9.5.18.1. Company Overview
      • 9.5.18.2. Financial Performance
      • 9.5.18.3. Product and Service Benchmarking
      • 9.5.18.4. Strategic Initiatives